Surface Oncology

Surface Oncology Pauses CD39 Program, Slashes Workforce by 20%
BioSpace
Wed, 11/2/22 - 10:47 pm
Surface Oncology
CD39
layoffs
SRF617
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
Why Surface Oncology Is Flying Higher After Hours Today
Motley Fool
Tue, 03/30/21 - 10:17 pm
Surface Oncology
FDA
cancer
regulatory
Surface Oncology To Test SRF388 Plus Keytruda Combo In Solid Tumor Settings
Benzinga
Tue, 03/9/21 - 09:39 pm
Surface Oncology
Merck
Keytruda
SRF388
solid tumors
GSK puts up to $815M on the table for Surface Oncology's antibody
Fierce Biotech
Thu, 12/17/20 - 11:18 am
GSK
Surface Oncology
SRF813
Upcoming events – key tests approach for Kadmon and Surface
EP Vantage
Fri, 11/1/19 - 06:53 pm
Kadmon
graft vs host disease
Surface Oncology
SRF373/NZV930
Surface Oncology Banks $119.5 Million With IPO and Private Placement
CP Wire
Tue, 04/24/18 - 09:08 am
Surface Oncology
IPOs
Surface Oncology Banks $119.5 Million With IPO and Private Placement
Mon, 04/23/18 - 08:20 pm
Surface Oncology
In knockout IPO offerings, MorphoSys and Surface Oncology haul combined $316M in upsized deals
Endpoints
Fri, 04/20/18 - 09:46 am
IPOs
MorphoSys
Surface Oncology
NASDAQ
Novartis provides $170M to kick off Surface Oncology partnership
Fierce Biotech
Mon, 01/11/16 - 11:56 am
Novartis
Surface Oncology
cancer immunotherapy
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Wed, 09/30/15 - 09:51 am
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics